Citations

Clear

4802 citation(s) found for "Yu, Jennifer".

Three Adjacent Temporal Defects
Rorex, Jennifer N. , Fathizadeh, Sam, Fathi, Ramin, Fathizadeh, Sam

Mayo Clinic

Dermatologic Surgery | September 1, 2021 | Volume: 48 | Issue: 10 | Pages: 1101-1103

10.1097/dss.0000000000003226 | PMID 34468412 Get It

Examining Burnout in Interprofessional Intensive Care Unit Clinicians Using Qualitative Analysis
Colbenson, Gretchen A. , Ridgeway, Jennifer L. , Benzo, Roberto P. , Kelm, Diana J. , Ridgeway, Jennifer L

Mayo Clinic

American Journal of Critical Care | September 1, 2021 | Volume: 30 | Issue: 5 | Pages: 391-396

10.4037/ajcc2021423 | PMID 34467381 Get It

Background Health care professionals working in intensive care units report a high degree of burnout, but this topic has not been extensively studied from an interdisciplinary perspective. Objective To characterize experiences of burnout among members of interprofessional intensive care unit teams and identify possible contributing factors. Methods This qualitative study involved interviews of registered nurses, respiratory therapists, physicians, pharmacists, and a personal care assistant working in multiple intensive care units of a single academic medical center to assess work stressors. Results Team composition was a factor in burnout, particularly when nonphysician team members felt that their opinions were not valued despite the institution’s emphasis on a multidisciplinary team-based model of care. This was especially true when roles were not well defined at the outset of a code situation. Members of nearly all disciplines stated that there was not enough time in a day to complete all the required tasks. Conclusions Multiple factors contribute to work-related stress and burnout across different professions in the intensive care unit. Improved communication and increased receptivity to diverse opinions among members of the multidisciplinary team may help reduce stress.
Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System
Lacy, Brian E. , Moshiree, Baha , Kassebaum, Amy, Abel, Jessica L. , Hanlon, Jennifer, Bartolini, Wilmin , Boinpally, Ramesh , Bochenek, Wieslaw, Fox, Susan M., Mallick, Madhuja, Tripp, Ken, Omniewski, Nicholas, Shea, Elizabeth P., Borgstein, Niels, Chang, Lin

Mayo Clinic

American Journal of Gastroenterology | September 1, 2021 | Volume: 116 | Issue: 9 | Pages: 1929-1937

10.14309/ajg.0000000000001334 | PMID 34465695 Get It

INTRODUCTION: Linaclotide improves abdominal pain and constipation in patients with constipation-predominant irritable bowel syndrome (IBS-C). Patients report additional bothersome abdominal symptoms of bloating and discomfort. The intention of this study was to evaluate linaclotide's efficacy in relieving IBS-C-related abdominal symptoms (bloating, discomfort, and pain) using a novel multi-item Abdominal Score (AS). METHODS: Patients with IBS-C with abdominal pain ≥3 (0–10 scale) were randomized to linaclotide 290 μg or placebo daily for 12 weeks. The AS, derived from the Diary for IBS Symptoms-Constipation, is the average of abdominal bloating, discomfort, and pain at their worst (0 = none, 10 = worst possible). The primary end point was overall change from baseline (CFB) in AS. Secondary end points included CFB in 12-week AS evaluated using cumulative distribution function and 6-week/12-week AS responder (AS improvement ≥2 points for ≥6-week/12-week). RESULTS: Overall, 614 patients (mean age 46.7 years; 81% female) were randomized. All prespecified end points showed significant benefit of linaclotide vs placebo. The mean overall CFB AS reduction for linaclotide was −1.9 vs −1.2 for placebo ( P < 0.0001); the 6-week/12-week AS responder rate was 40.5% for linaclotide vs 23.4% for placebo (odds ratio = 2.2 [95% confidence interval, 1.55–3.12; P < 0.0001]). Diarrhea was the most common treatment-emergent adverse event (linaclotide = 4.6%, placebo = 1.6%). DISCUSSION: Linaclotide significantly reduced multiple abdominal symptoms important to patients with IBS-C (bloating, discomfort, and pain) compared with placebo, as measured by a novel multi-item AS. The AS, derived from the Diary for IBS Symptoms-Constipation, should be considered for use in future IBS-C clinical studies to measure clinically meaningful improvements beyond traditional end points.
Envisioning Future Urinary Tract Infection Diagnostics
Patel, Robin , Bard, Jennifer Dien , May, Larissa, Lee, Francesca M, Hayden, Mary K. , Doernberg, Sarah D B, Haake, David A. , Grigoryan, Larissa, Tsalik, Ephraim L. , Hanson, Kimberly E. , Grigoryan, Larissa , Patel, Robin , Hanson, Kimberly , Grigoryan, Larissa , Polage, Christopher R. , Fabre, Valeria , Doernberg, Sarah B. , Trautner, Barbara W.

Mayo Clinic

Clinical Infectious Diseases | August 31, 2021 | Volume: 74 | Issue: 7 | Pages: 1284-1292

10.1093/cid/ciab749 | PMID 34463708 Get It

Abstract Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.
Vitamin D Status and Severe COVID-19 Disease Outcomes in Hospitalized Patients
Pecina, Jennifer L. , Merry, Stephen , Park, John G. , Thacher, Tom D. , Merry, Stephen P , Pecina, Jennifer , Thacher, Thomas D

Mayo Clinic

Journal of Primary Care & Community Health | August 28, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211041206 | PMID 34452582 Get It

Background: Vitamin D deficiency may increase the risk of severe COVID-19 disease. Objectives: To determine if 25-hydroxyvitamin D [25(OH)D] levels in patients hospitalized for COVID-19 were associated with the clinical outcomes of days on oxygen, duration of hospitalization, ICU admission, need for assisted ventilation, or mortality. Methods: We conducted a retrospective study of 92 patients admitted to the hospital with SARS-CoV-2 infection between April 16, 2020 and October 17, 2020. Multivariable regression was performed to assess the independent relationship of 25(OH)D values on outcomes, adjusting for significant covariates and the hospitalization day the level was tested. Results: About 15 patients (16.3%) had 25(OH)D levels <20 ng/mL. Only 1 patient (3.4%) who had documented vitamin D supplementation prior to admission had 25(OH)D <20 ng/mL. Serum 25(OH)D concentrations were not significantly associated with any of our primary outcomes of days on oxygen, duration of hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, or mortality in any of the adjusted multivariable models. Adjusting for the hospital day of 25(OH)D sampling did not alter the relationship of 25(OH)D with any outcomes. Conclusion: Vitamin D status was not related to any of the primary outcomes reflecting severity of COVID-19 in hospitalized patients. However, our sample size may have lacked sufficient power to demonstrate a small effect of vitamin D status on these outcomes.
Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial
Lazar, Ronald M. , Wadley, Virginia G., Myers, Terina , Jones, Michael R., Heck, Donald V., Clark, Wayne M. , Marshall, Randolph S. , Howard, Virginia J., Voeks, Jenifer H., Manly, Jennifer J. , Moy, Claudia S., Chaturvedi, Seemant, Meschia, James F., Lal, Brajesh K. , Brott, Thomas G., Howard, George, Howard, Virginia J. , Howard, Virginia J , Manly, Jennifer J , Lazar, Ronald M , Wadley, Virginia G., Myers, Terina , Jones, Michael R., Heck, Donald V., Clark, Wayne M. , Marshall, Randolph S. , Voeks, Jenifer H., Moy, Claudia S., Chaturvedi, Seemant, Meschia, James F., Lal, Brajesh , Brott, Thomas G., Howard, George

Mayo Clinic

Stroke | August 26, 2021 | Volume: 52 | Issue: 12 | Pages: 3855-3863

10.1161/strokeaha.120.032972 | PMID 34433306 Get It

Background and Purpose: Studies of carotid artery disease have suggested that high-grade stenosis can affect cognition, even without stroke. The presence and degree of cognitive impairment in such patients have not been reported and compared with a demographically matched population-based cohort. Methods: We studied cognition in 1000 consecutive CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) patients, a treatment trial for asymptomatic carotid disease. Cognitive assessment was after randomization but before assigned treatment. The cognitive battery was developed in the general population REGARDS Study (Reasons for Geographic and Racial Differences in Stroke), involving Word List Learning Sum, Word List Recall, and Word List fluency for animal names and the letter F. The carotid stenosis patients were >45 years old with ≥70% asymptomatic carotid stenosis and no history of prevalent stroke. The distribution of cognitive performance for the patients was standardized, accounting for age, race, and education using performance from REGARDS, and after further adjustment for hypertension, diabetes, dyslipidemia, and smoking. Using the Wald Test, we tabulated the proportion of Z scores less than the anticipated deviate for the population-based cohort for representative percentiles. Results: There were 786 baseline assessments. Mean age was 70 years, 58% men, and 52% right-sided stenosis. The overall Z score for patients was significantly below expected for higher percentiles ( P <0.0001 for 50th, 75th, and 95th percentiles) and marginally below expected for the 25th percentile ( P =0.015). Lower performance was attributed largely to Word List Recall ( P <0.0001 for all percentiles) and for Word List Learning (50th, 75th, and 95th percentiles below expected, P ≤0.01). The scores for left versus right carotid disease were similar. Conclusions: Baseline cognition of patients with severe carotid stenosis showed below normal cognition compared to the population-based cohort, controlling for demographic and cardiovascular risk factors. This cohort represents the largest group to date to demonstrate that poorer cognition, especially memory, in this disease. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02089217.
Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy
Tosakulwong, Nirubol , Weigand, Stephen D. , Ali, Farwa , Pham, Nha Trang Thu, Senjem, Matthew L. , Jack, Clifford R. , Lowe, Val J. , Ahlskog, J. Eric , Josephs, Keith A. , Whitwell, Jennifer L. , Josephs, Keith A , Whitwell, Jennifer , Jack, Clifford R , Senjem, Matthew L , Clark, Heather M. , Botha, Hugo , Schwarz, Christopher G. , Reid, Robert I.

Mayo Clinic

Movement Disorders | August 24, 2021 | Volume: 36 | Issue: 11 | Pages: 2669-2675

10.1002/mds.28731 | PMID 34426998 Get It

AbstractBackgroundDysphagia is a common symptom of progressive supranuclear palsy often leading to aspiration pneumonia and death.ObjectiveThe aim of this study was to examine how impairments of the oral and pharyngeal phases of the swallow and airway incursion during liquid swallows relate to gray and white matter integrity.MethodsThirty‐eight participants with progressive supranuclear palsy underwent videofluorographic swallowing assessment and structural and diffusion tensor head magnetic resonance imaging. Penalized linear regression models assessed relationships between swallowing metrics and regional gray matter volumes and white matter fractional anisotropy and mean diffusivity.ResultsOral phase impairments were associated with reduced superior parietal volumes and abnormal diffusivity in parietal and sensorimotor white matter, posterior limb of the internal capsule, and superior longitudinal fasciculus. Pharyngeal phase impairments were associated with disruption to medial frontal lobe, corticospinal tract, and cerebral peduncle. No regions were predictive of airway incursion.ConclusionsDifferential patterns of neuroanatomical impairment corresponded to oral and pharyngeal phase swallowing impairments. © 2021 International Parkinson and Movement Disorder Society
Risk Factors for Critical Coronavirus Disease 2019 and Mortality in Hospitalized Young Adults: An Analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 Registry
Sayed, Imran A., Dapul, Heda , McGarvey, Jeremy , Bandy, Jennifer A., Boman, Karen , Kumar, Vishakha K. , Bansal, Vikas , Retford, Lynn, Kaufman, Margit, Heavner, Smith F. , Danesh, Valerie , Hill, Catherine A. St., Bhalala, Utpal , Koritala, Thoyaja , Заболотских, И. Б. , Asghar, Muhammad Sohaib , Iwasaki, Yudai , Tarabichi, Yasir , Bansal, Vikas , Asghar, Muhammad S , Tripathi, Sandeep , Cheruku, Sreekanth , Khanna, Ashish K. , Kashyap, Rahul , Gajic, Ognjen , Walkey, Allan J. , Gist, Katja M.

Mayo Clinic

Critical Care Explorations | August 20, 2021 | Volume: 3 | Issue: 8 | Pages: e0514

10.1097/cce.0000000000000514 | PMID 34476401 Get It

IMPORTANCE: Even with its proclivity for older age, coronavirus disease 2019 has been shown to affect all age groups. However, there remains a lack of research focused primarily on the young adult population. OBJECTIVES: To describe the epidemiology and outcomes of coronavirus disease 2019 and identify the risk factors associated with critical illness and mortality in hospitalized young adults. DESIGN, SETTINGS, AND PARTICIPANTS: A retrospective cohort study of the Society of Critical Care Medicine’s Viral Infection and Respiratory Illness Universal Study registry. Patients 18–40 years old, hospitalized from coronavirus disease 2019 from March 2020 to April 2021, were included in the analysis. MAIN OUTCOMES AND MEASURES: Critical illness was defined as a composite of mortality and 21 predefined interventions and complications. Multivariable logistic regression was used to assess associations with critical illness and mortality. RESULTS: Data from 4,005 patients (152 centers, 19 countries, 18.6% non-U.S. patients) were analyzed. The median age was 32 years (interquartile range, 27–37 yr); 51% were female, 29.4% Hispanic, and 42.9% had obesity. Most patients (63.2%) had comorbidities, the most common being hypertension (14.5%) and diabetes (13.7%). Hospital and ICU mortality were 3.2% (129/4,005) and 8.3% (109/1,313), respectively. Critical illness occurred in 25% (n = 996), and 34.3% (n = 1,376) were admitted to the ICU. Older age (p = 0.03), male sex (adjusted odds ratio, 1.83 [95% CI, 1.2–2.6]), and obesity (adjusted odds ratio, 1.6 [95% CI, 1.1–2.4]) were associated with hospital mortality. In addition to the above factors, the presence of any comorbidity was associated with critical illness from coronavirus disease 2019. Multiple sensitivity analyses, including analysis with U.S. patients only and patients admitted to high-volume sites, showed similar risk factors. CONCLUSIONS: Among hospitalized young adults, obese males with comorbidities are at higher risk of developing critical illness or dying from coronavirus disease 2019.